Company Filing History:
Years Active: 2023
Title: Kathryn E Aman: Innovator in Neuromodulation Technology
Introduction
Kathryn E Aman is a notable inventor based in St. Anthony, MN, who has made significant contributions to the field of neuromodulation technology. With two patents to her name, she has developed innovative methods and apparatuses that enhance the functionality and efficiency of neurostimulator devices.
Latest Patents
Her latest patents include a method for replacing an implanted neuromodulation device and an adaptor for electrically coupling a previously implanted stimulation lead with a replacement neurostimulator device. The first patent outlines a method that involves explanting a previously implanted neurostimulator device and operably coupling a replacement device to a stimulation lead. This method is particularly significant as it allows for the implantation of a smaller replacement device, which has a volume of about ten cc's or less, compared to the previously implanted device that has a volume greater than ten cc's. The second patent describes an apparatus and method designed to facilitate the electrical connection between a previously implanted stimulation lead and a replacement neurostimulator device, ensuring seamless integration and functionality.
Career Highlights
Kathryn works at Medtronic, Inc., a leading company in medical technology. Her work focuses on advancing neuromodulation solutions that improve patient outcomes. Her innovative approaches have positioned her as a key player in the development of next-generation neurostimulator devices.
Collaborations
Throughout her career, Kathryn has collaborated with esteemed colleagues, including Robert T Sandgren and Elizabeth K Formosa. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of neuromodulation.
Conclusion
Kathryn E Aman is a pioneering inventor whose work in neuromodulation technology has the potential to transform patient care. Her patents reflect her commitment to innovation and excellence in medical technology.